坏死性凋亡信号促进慢阻肺炎症、气道重塑与肺气肿
该研究在慢阻肺患者肺组织及香烟烟雾诱导的小鼠实验性慢阻肺中检测坏死性凋亡相关分子,发现重度慢阻肺患者气道上皮和巨噬细胞总MLKL蛋白及肺组织pRIPK3、pMLKL升高。小鼠中敲除Ripk3或Mlkl可减轻香烟烟雾诱导的气道炎症,Mlkl缺失还阻止气道重塑与肺气肿,提示靶向抑制坏死性凋亡是慢阻肺潜在治疗策略。
要点
- 重度慢阻肺患者肺组织pRIPK3、pMLKL及上皮和巨噬细胞MLKL蛋白升高
- 小鼠敲除Ripk3或Mlkl减轻急性香烟烟雾暴露所致气道炎症
- Mlkl缺失可阻止慢性香烟烟雾诱导的气道重塑与肺气肿
核心结论
- 坏死性凋亡由香烟烟雾暴露诱导,在慢阻肺患者肺组织和实验性慢阻肺中增加。
- 抑制坏死性凋亡可减轻香烟烟雾诱导的气道炎症、气道重塑和肺气肿。
- 靶向抑制坏死性凋亡是慢阻肺的潜在治疗策略。
研究设计与样本
- 在慢阻肺患者与无慢阻肺对照者的肺组织中检测总RIPK3、总MLKL及磷酸化RIPK3、磷酸化MLKL。
- 在香烟烟雾诱导的实验性慢阻肺小鼠中检测肺和肺巨噬细胞的坏死性凋亡相关mRNA、蛋白及细胞死亡。
- 比较Ripk3-/-、Mlkl-/-小鼠与野生型小鼠对急性和慢性香烟烟雾暴露的反应。
- 评估泛caspase抑制剂qVD-OPh抑制凋亡联合Mlkl缺失抑制坏死性凋亡的效果。
主要发现
- 重度慢阻肺患者上皮和巨噬细胞总MLKL蛋白及肺组织pRIPK3、pMLKL较从不吸烟者或无慢阻肺吸烟对照升高。
- 香烟烟雾暴露小鼠及实验性慢阻肺的肺和巨噬细胞中坏死性凋亡相关mRNA和蛋白水平升高。
- Ripk3或Mlkl缺失阻止急性香烟烟雾暴露后的气道炎症。
- Ripk3缺失减轻慢性香烟烟雾暴露后的气道炎症、气道重塑及肺气肿病理。
- Mlkl缺失和qVD-OPh治疗减轻慢性香烟烟雾诱导的气道炎症,但仅Mlkl缺失阻止气道重塑和肺气肿;Ripk3或Mlkl缺失及qVD-OPh治疗均减少香烟烟雾诱导的肺细胞死亡。
临床怎么用
- 对重度慢阻肺患者肺组织可关注RIPK3/MLKL通路活化状态,作为机制相关标志物。
- 动物证据提示抑制坏死性凋亡(如Mlkl缺失)可能减轻气道炎症、重塑和肺气肿,但尚未转化为临床推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Necroptosis, mediated by RIPK3 (receptor-interacting protein kinase 3) and MLKL (mixed lineage kinase domain-like), is a form of regulated necrosis that can drive tissue inflammation and destruction; however, its contribution to chronic obstructive pulmonary disease (COPD) pathogenesis is poorly understood. Objectives: To determine the role of necroptosis in COPD. Methods: Total and active (phosphorylated) RIPK3 and MLKL were measured in the lung tissue of patients with COPD and control subjects without COPD. Necroptosis-related mRNA and proteins as well as cell death were examined in lungs and pulmonary macrophages of mice with cigarette smoke (CS)-induced experimental COPD. The responses of Ripk3-/- and Mlkl-/- mice to acute and chronic CS exposure were compared with those of wild-type mice. The combined inhibition of apoptosis (with the pan-caspase inhibitor quinoline-Val-Asp-difluorophenoxymethylketone [qVD-OPh]) and necroptosis (with deletion of Mlkl in mice) was assessed. Measurements and Main Results: The total MLKL protein in the epithelium and macrophages and the pRIPK3 and pMLKL in lung tissue were increased in patients with severe COPD compared with never-smokers or smoker control subjects without COPD. Necroptosis-related mRNA and protein levels were increased in the lungs and macrophages in CS-exposed mice and experimental COPD. Ripk3 or Mlkl deletion prevented airway inflammation upon acute CS exposure. Ripk3 deficiency reduced airway inflammation and remodeling as well as the development of emphysematous pathology after chronic CS exposure. Mlkl deletion and qVD-OPh treatment reduced chronic CS-induced airway inflammation, but only Mlkl deletion prevented airway remodeling and emphysema. Ripk3 or Mlkl deletion and qVD-OPh treatment reduced CS-induced lung-cell death. Conclusions: Necroptosis is induced by CS exposure and is increased in the lungs of patients with COPD and in experimental COPD. Inhibiting necroptosis attenuates CS-induced airway inflammation, airway remodeling, and emphysema. Targeted inhibition of necroptosis is a potential therapeutic strategy in COPD.
引用
- Lu Z, Van Eeckhoutte HP, Liu G, et al. Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021. PMID: 34133911. doi:10.1164/rccm.202009-3442OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。